Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 229

1.

Cardiovascular disease mortality in patients with genetically verified familial hypercholesterolemia in Norway during 1992-2013.

Mundal L, Igland J, Ose L, Holven KB, Veierød MB, Leren TP, Retterstøl K.

Eur J Prev Cardiol. 2017 Jan;24(2):137-144. doi: 10.1177/2047487316676135. Epub 2016 Oct 28.

PMID:
27794106
2.

Cardiovascular disease in patients with genotyped familial hypercholesterolemia in Norway during 1994-2009, a registry study.

Mundal L, Veierød MB, Halvorsen T, Holven KB, Ose L, Iversen PO, Tell GS, Leren TP, Retterstøl K.

Eur J Prev Cardiol. 2016 Dec;23(18):1962-1969. doi: 10.1177/2047487316666371. Epub 2016 Sep 27.

PMID:
27558979
3.

Dietary counseling is associated with an improved lipid profile in children with familial hypercholesterolemia.

Torvik K, Narverud I, Ottestad I, Svilaas A, Gran JM, Retterstøl K, Ellingvåg A, Strøm E, Ose L, Veierød MB, Holven KB.

Atherosclerosis. 2016 Sep;252:21-7. doi: 10.1016/j.atherosclerosis.2016.07.913. Epub 2016 Jul 22.

PMID:
27494447
4.

Long-term follow-up of young adults with familial hypercholesterolemia after participation in clinical trials during childhood.

Langslet G, Bogsrud MP, Halvorsen I, Fjeldstad H, Retterstøl K, Veierød MB, Ose L.

J Clin Lipidol. 2015 Nov-Dec;9(6):778-785. doi: 10.1016/j.jacl.2015.08.008. Epub 2015 Aug 29.

PMID:
26687698
5.

Maternal inheritance does not predict cholesterol levels in children with familial hypercholesterolemia.

Narverud I, van Lennep JR, Christensen JJ, Versmissen J, Gran JM, Iversen PO, Aukrust P, Halvorsen B, Ueland T, Ulven SM, Ose L, Veierød MB, Sijbrands E, Retterstøl K, Holven KB.

Atherosclerosis. 2015 Nov;243(1):155-60. doi: 10.1016/j.atherosclerosis.2015.09.014. Epub 2015 Sep 9.

PMID:
26386212
6.

[Increased mortality in familial hypercholesterolemia].

Mundal L, Sarancic M, Ose L, Iversen PO, Borgan JK, Veierød MB, Leren TP, Retterstøl K.

Tidsskr Nor Laegeforen. 2015 Jun 16;135(11):1024-5. doi: 10.4045/tidsskr.15.0244. eCollection 2015 Jun 16. Norwegian. No abstract available.

7.

Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment.

Wiegman A, Gidding SS, Watts GF, Chapman MJ, Ginsberg HN, Cuchel M, Ose L, Averna M, Boileau C, Borén J, Bruckert E, Catapano AL, Defesche JC, Descamps OS, Hegele RA, Hovingh GK, Humphries SE, Kovanen PT, Kuivenhoven JA, Masana L, Nordestgaard BG, Pajukanta P, Parhofer KG, Raal FJ, Ray KK, Santos RD, Stalenhoef AF, Steinhagen-Thiessen E, Stroes ES, Taskinen MR, Tybjærg-Hansen A, Wiklund O; European Atherosclerosis Society Consensus Panel.

Eur Heart J. 2015 Sep 21;36(36):2425-37. doi: 10.1093/eurheartj/ehv157. Epub 2015 May 25. Review.

8.

Mortality among patients with familial hypercholesterolemia: a registry-based study in Norway, 1992-2010.

Mundal L, Sarancic M, Ose L, Iversen PO, Borgan JK, Veierød MB, Leren TP, Retterstøl K.

J Am Heart Assoc. 2014 Dec 2;3(6):e001236. doi: 10.1161/JAHA.114.001236.

9.

Identifying genetic risk variants for coronary heart disease in familial hypercholesterolemia: an extreme genetics approach.

Versmissen J, Oosterveer DM, Yazdanpanah M, Dehghan A, Hólm H, Erdman J, Aulchenko YS, Thorleifsson G, Schunkert H, Huijgen R, Vongpromek R, Uitterlinden AG, Defesche JC, van Duijn CM, Mulder M, Dadd T, Karlsson HD, Ordovas J, Kindt I, Jarman A, Hofman A, van Vark-van der Zee L, Blommesteijn-Touw AC, Kwekkeboom J, Liem AH, van der Ouderaa FJ, Calandra S, Bertolini S, Averna M, Langslet G, Ose L, Ros E, Almagro F, de Leeuw PW, Civeira F, Masana L, Pintó X, Simoons ML, Schinkel AF, Green MR, Zwinderman AH, Johnson KJ, Schaefer A, Neil A, Witteman JC, Humphries SE, Kastelein JJ, Sijbrands EJ.

Eur J Hum Genet. 2015 Mar;23(3):381-7. doi: 10.1038/ejhg.2014.101. Epub 2014 Jun 11.

10.

Markers of atherosclerotic development in children with familial hypercholesterolemia: a literature review.

Narverud I, Retterstøl K, Iversen PO, Halvorsen B, Ueland T, Ulven SM, Ose L, Aukrust P, Veierød MB, Holven KB.

Atherosclerosis. 2014 Aug;235(2):299-309. doi: 10.1016/j.atherosclerosis.2014.05.917. Epub 2014 May 20. Review.

PMID:
24908240
11.

Subjects with familial hypercholesterolemia are characterized by an inflammatory phenotype despite long-term intensive cholesterol lowering treatment.

Holven KB, Narverud I, Lindvig HW, Halvorsen B, Langslet G, Nenseter MS, Ulven SM, Ose L, Aukrust P, Retterstøl K.

Atherosclerosis. 2014 Apr;233(2):561-7. doi: 10.1016/j.atherosclerosis.2014.01.022. Epub 2014 Jan 24.

PMID:
24530965
12.

Subjects with low plasma HDL cholesterol levels are characterized by an inflammatory and oxidative phenotype.

Holven KB, Retterstøl K, Ueland T, Ulven SM, Nenseter MS, Sandvik M, Narverud I, Berge KE, Ose L, Aukrust P, Halvorsen B.

PLoS One. 2013 Nov 11;8(11):e78241. doi: 10.1371/journal.pone.0078241. eCollection 2013.

13.

Low level of inflammatory marker in hyperhomocysteinemic patients on statin therapy.

Nenseter MS, Aukrust P, Ose L, Holven KB.

Scand J Clin Lab Invest. 2014 Jan;74(1):1-7. doi: 10.3109/00365513.2013.854926. Epub 2013 Nov 18.

PMID:
24236948
14.

Screening methods in the diagnosis and assessment of children and adolescents with familial hypercholesterolemia.

Langslet G, Ose L.

Expert Rev Cardiovasc Ther. 2013 Aug;11(8):1061-6. doi: 10.1586/14779072.2013.814851. Review.

PMID:
23984929
15.

The impact of variability in ultrasound settings on the measured echolucency of the carotid intima-media.

Peters SA, Bots ML, Lind L, Groenewegen KA, de Korte C, den Ruijter HM; METEOR study group.

J Hypertens. 2013 Sep;31(9):1861-7. doi: 10.1097/HJH.0b013e3283623548.

PMID:
23868083
16.

Phytosterol capsules and serum cholesterol in hypercholesterolemia: a randomized controlled trial.

Ottestad I, Ose L, Wennersberg MH, Granlund L, Kirkhus B, Retterstøl K.

Atherosclerosis. 2013 Jun;228(2):421-5. doi: 10.1016/j.atherosclerosis.2013.03.001. Epub 2013 Mar 20.

PMID:
23623012
17.

Cholesterol efflux mediators in homozygous familial hypercholesterolemia patients on low-density lipoprotein apheresis.

Nenseter MS, Narverud I, Græsdal A, Bogsrud MP, Aukrust P, Retterstøl K, Ose L, Halvorsen B, Holven KB.

J Clin Lipidol. 2013 Mar-Apr;7(2):109-16. doi: 10.1016/j.jacl.2012.08.001. Epub 2012 Aug 8.

PMID:
23415429
18.

No effect of combined coenzyme Q10 and selenium supplementation on atorvastatin-induced myopathy.

Bogsrud MP, Langslet G, Ose L, Arnesen KE, Sm Stuen MC, Malt UF, Woldseth B, Retterstøl K.

Scand Cardiovasc J. 2013 Apr;47(2):80-7. doi: 10.3109/14017431.2012.756119. Epub 2013 Jan 10.

PMID:
23301875
19.

Children and young adults with familial hypercholesterolaemia (FH) have healthier food choices particularly with respect to dietary fat sources compared with non-FH children.

Molven I, Retterstøl K, Andersen LF, Veierød MB, Narverud I, Ose L, Svilaas A, Wandel M, Holven KB.

J Nutr Sci. 2013 Oct 11;2:e32. doi: 10.1017/jns.2013.27. eCollection 2013.

20.

Maternal familial hypercholesterolaemia (FH) confers altered haemostatic profile in offspring with and without FH.

Narverud I, Iversen PO, Aukrust P, Halvorsen B, Ueland T, Johansen SG, Nenseter MS, Sandset PM, Ulven SM, Ose L, Retterstøl K, Holven KB.

Thromb Res. 2013 Feb;131(2):178-82. doi: 10.1016/j.thromres.2012.11.008. Epub 2012 Nov 28.

PMID:
23199546

Supplemental Content

Loading ...
Support Center